English
Español
DeutschNews & Media
How to support cancer patients, despite side-effects, to persevere with prescribed treatment
Dr Judith Kalthoff, Clinical Psychologist
Cancer is listed amongst the four leading threats to physical health and well-being worldwide (WHO, 2008). It has been estimated that 21.4 million cases will be diagnosed each year and mortality rates will rise up to 13.2 million by 2030 (GLOBOCAN, 2008). The importance of patients taking their medication as prescribed, in order to optimise treatment outcomes and increase survivorship is bought into sharp focus by these increasing figures.
IBM's Reinvention Should Inspire Flat Pharma Businesses
Author: David Chase
Published on Forbes
The pharmaceutical giants look remarkably similar to the IBM of the late 80s and early 90s. For those of us who remember the IBM of that era, this is bad news.
International Congress on Telehealth and Telecare 2012 – London
During the second annual International Congress on Telehealth and Telecare in London in March, presenters shared experiences and showcased ideas, research and innovations in telehealth and telecare that improve the care of people with long-term conditions and other health and social care needs.
Health Psychology Specialist Profile - Dr Lina Eliasson
As a Clinical Strategist in Atlantis Healthcare's Global Solutions team, Dr Lina Eliasson is responsible for ensuring patient support programmes developed by the clinical team are done to the highest standard within the constraints of a commercial environment.
Nil by mouth?
It would be easy to assume that an oral treatment that can halt the progression of a rare form of leukaemia would have high rates of adherence. But as respected health psychology specialists Dr Lina Eliasson and Antonia Rich have found, this is not necessarily the case. In this article we look at why adherence is an issue for sufferers of Chronic Myeloid Leukaemia (CML), and what can be done to address it.
Making academic innovation count
As universities come under increasing pressure to play a more commercial role in the world, academics with bright ideas should be actively seeking partnerships with entrepreneurs and relevant companies in their field, says Nick Watkins, Managing Partner of private investor, White Cloud Capital and 50 per cent shareholder of Atlantis Healthcare.
Page 2 of 23